Loading viewer...
investor_presentation
Format: PDF investor_presentation
ImmunityBio presents updates on ANKTIVA approval and commercial launch, global regulatory filing status, and safety and efficacy data. The presentation covers ANKTIVA mechanism of action, BCG naïve clinical data, and manufacturing partnership with Serum Institute of India, alongside the company's pipeline overview.
investor_presentation
25 Pages
Metso Outotec
Münchener Rückversicherungs-Gesellschaft Investor Presentation — August 2019
investor_presentationinvestor_presentation
49 Pages
Münchener Rückversicherungs-Gesellschaft